Cite
HARVARD Citation
Wolfe, Z. et al. (2022). Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma. Melanoma research. 32 (4), pp. 295-298. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wolfe, Z. et al. (2022). Case report: response to the ERK1/2 inhibitor ulixertinib in BRAF D594G cutaneous melanoma. Melanoma research. 32 (4), pp. 295-298. [Online].